Iterum Therapeutics PLC (ITRM)

1.55 -0.03 (-1.90%) USD  |  NASDAQ  |  May 03, 16:00
1.53 -0.02 (-1.29%) After-Hours: 20:00
More

Iterum Therapeutics Cash from Operations (Quarterly): -12.84M for Dec. 31, 2023

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Upgrade now.
Date Value
December 31, 2023 -12.84M
September 30, 2023 -9.265M
June 30, 2023 -7.632M
March 31, 2023 -9.59M
December 31, 2022 -4.265M
September 30, 2022 -4.539M
June 30, 2022 -6.264M
March 31, 2022 -3.405M
December 31, 2021 -2.459M
September 30, 2021 -3.91M
June 30, 2021 -8.341M
March 31, 2021 -1.132M
December 31, 2020 -9.031M
September 30, 2020 -4.417M
Date Value
June 30, 2020 -13.69M
March 31, 2020 -27.39M
December 31, 2019 -23.05M
September 30, 2019 -25.41M
June 30, 2019 -18.41M
March 31, 2019 -15.05M
December 31, 2018 -25.19M
September 30, 2018 -27.50M
June 30, 2018 -12.93M
March 31, 2018 -11.64M
December 31, 2017 -10.12M
September 30, 2017 -5.437M
June 30, 2017 -9.609M
March 31, 2017 -5.435M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-27.39M
Minimum
Mar 2020
-1.132M
Maximum
Mar 2021
-10.27M
Average
-8.341M
Median
Jun 2021

Cash from Operations (Quarterly) Benchmarks

Alkermes PLC 21.11M
Endo International PLC 115.06M
Jazz Pharmaceuticals PLC 267.23M
Medtronic PLC 2.474B
Perrigo Co PLC 208.70M

Cash from Operations (Quarterly) Related Metrics

Cash from Investing (Quarterly) 13.52M
Cash from Financing (Quarterly) 0.589M
Free Cash Flow -39.34M
Free Cash Flow Per Share (Quarterly) -0.9742
Free Cash Flow Yield -195.8%